Microvascular repair following a modified crush-avulsion injury in a rat model: Effect of recombinant human tissue-type plasminogen activator on the patency rate

Microsurgery

Volumn 20, Issue 2, 2000, Pages 52-58

  Lykoudis, Efstathios G ^a,b   Panayotou, Petros N ^a   Stamatopoulos, Constantinos N ^a   Frangia, Konstantina B ^a   Papalois, Apostolos E ^a   Ioannovich, John D ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTERY BLOOD FLOW; ARTERY THROMBOSIS; ARTICLE; AVULSION INJURY; CONTROLLED STUDY; CRUSH TRAUMA; DRUG EFFECT; FEMORAL ARTERY; GRAFT PATENCY; LEG REVASCULARIZATION; MALE; MICROVASCULAR SURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; REIMPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; EVALUATION STUDIES; FEMORAL ARTERY; FIBRINOLYTIC AGENTS; HUMANS; MALE; MICROSURGERY; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 0034059768     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2752(2000)20:2<52::AID-MICR2>3.0.CO;2-G     Document Type: Article

References (24)

1. Arnljots B, Wieslander JB, Dougan P, Salemark L. Prevention of microvascular thrombosis with low dose tissue plasminogen activator. Plast Reconstr Surg 1992;90:281-288.
2. Verstraete M. Use of thrombolytic drugs in non-coronary disorders. Drugs 1989;38:801-821.
3. Merle M, Dautel G. Advances in digital replantation. Clin Plast Surg 1997;24:87-105.
4. Lutz BS, Klauke T, Dietrich FE. Late results after microvascular reconstruction of severe crush and avulsion injuries of the upper extremity. J Reconstr Microsurg 1997;13:423-429.
5. Malardy D, Bernard V, Dupuis P, Mitz V, Lamerle JP. Scalp reconstruction after avulsion: emergency microsurgery and secondary tissue expansion. Apropos of 3 cases caused by farming machines. Ann Chir Plast Esthet 1994;39:169-175.
6. Stamatopoulos C, Biemer E, Puspiva W, Blutnmel G. Microvascular damage caused by the application of surgical microclips: the effects of pressure and time. Int J Microsurg 1980;2:181-186.
7. Cooley BC, Hansen FC. Microvascular repair following local crush and avulsion injury. Microsurgery 1985;6:46-48.
8. Karlander LE, Lidman D, Franzen L. The effect of severe contusion on the vessels of the femoral region. Scand J Plast Reconstr Hand Surg 1991;25:1-4.
9. Rooks MD, Rodriguez J, McNaughton M, Turnidge K, Zusmanis K, Hutton W. Refinement of the rat crush-avulsion femoral artery injury model. Microsurgery 1993;14:130-134.
10. Siegel DB. Use of anticoagulants in replantation and elective microsurgery. Microsurgery 1991;12:277-280.
11. Rooks MD, Rodriguez J, Blechner M, Zusmanis K, Hutton W. Comparative study of imraarterial and intravenous anticoagulants in microvascular anastomosis. Microsurgery 1994;15:123-129.
12. Khouri RK, Cooley BC, Kenna DM, Edstrom LE. Thrombosis of microvascular anastomoses in traumatized vessels: fibrin versus platelets. Plast Reconstr Surg 1990;86:110-117.
13. Chen LE, Korompilias AV, Urbaniak JR. Effects of enoxaparin, standard heparin and streptokinase on the patency of anastomoses in severely crushed arteries. Microsurgery 1995;16:661-665.
14. Arnljots B, Dougan P, Salemark L, Bergqvist D. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis. Scand J Plast Reconstr Hand Surg 1994;28:9-13.
15. Goldhaber SZ, Meyerovitz MF, Green D. et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990;88:235-240.
16. Martin M, Heimig T, Fiebach BJO, Magnus L, Riedel C. Lysis block treatment: a new form of local thrombolysis. Angiology 1994;45:143-148.
17. Zenz W, Muntean W, Beitzke A, Zobel G, Riccabona M, Gamillscheg A. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 1993;70:382-385.
18. d'Ivernois C, Metayer P, Fischer B, Haissaguerre M, Warin JF. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator. Chest 1994;105:1291-1292.
19. Gold HK, Fallon JT, Yasuda T, et al. Coronary thrombolysis with recombinant human tissue type plasminogen activator. Circulation 1984;70:700-707.
20. Califf RM, White HD, Van de Werf F, et al. One-year results from the global utilization of streptokinase and TPA for occluded coronary arteries (GUSTO-I) trial. Circulation 1996;94:1233-1238.
21. Stassen JM, Lu G, Andreen O, Nystrom E, Nystrom A. Intraoperative thrombolytic treatment of microatrerial occlusion by selective rt-PA infusion. Plast Reconstr Surg 1995;96:1215-1217.
22. Hergrueter CA, Handren J, Kersh R, May JW. Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit. Plast Reconstr Surg 1988;81:418-424.
23. Rohrich RJ, Handren J, Kersh R, Hergrueter CA, May JW. Prevention of microvascular thrombosis with short-term infusion of human tissue-type plasminogen activator. Plast Reconstr Surg 1996;98:118-128.
24. Matsuno H, Uematsu T, Nagashima S, Nakashima M. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 1991;25:303-317.